AHPI & AIMED sign MoU to Promote Indian Medical Devices Industry

S Singh
S Singh
· 3 min read
Dr.Girdhar Gyani , Director General, Padma Bhushan Dr. Devi Shetty, Dr. Alexander Thomas, President AHPI & Mr. Rajiv Nath, Forum Coordinator, AiMeD during the MoU signing

Association of Healthcare Providers of India (AHPI) and Association of Indian Medical Device Industry (AiMeD) on Saturday, 16th Feb, 2019 signed a memorandum of understanding (MoU) to support Make in India of Medical Devices to transform India into a global medical devices manufacturing hub and simultaneously promote the India Certification of Medical Devices Scheme (ICMED) country’s first indigenously developed international class quality assurance system for India manufactured medical devices.

The MoU was signed by Mr. Rajiv Nath, Forum Coordinator, AiMeD and Dr. Girdhar Gyani, Director General, AHPI. As per the MoU, AHPI and AIMED will work together to jointly promote Indian Medical Devices Industry and specially promote ICMED (from Quality Council of India) certified products in over 10000 member Indian hospitals aimed at enhancing patient safety, increasing consumer protection along with providing much needed product credentials to manufacturers to instill confidence among buyers. The scheme is also intended to significantly eliminate trading of sub-standard products or devices where supply chains are unknown, a widespread and injurious occurrence in the Indian market.

The move is likely to have a huge positive impact on ‘Make in India’ program while giving a big shot to manufacturing of medical devices within the country, promote Medical Devices manufactured in India as high quality products, promote “Buy Indian” initiatives and bring esteem to the Indian Industry & Nation thereby building Brand India.

Both AHPI and AIMED recognize specifically the need for setting up of an independent, multi stakeholder governing structure for the Scheme(s). AHPI shall operate the Scheme(s) by setting up independent multi-stakeholder steering committee(s) and any other committees necessary for the purpose in consultation with AiMeD.

AiMeD shall provide the technical documents developed by by QCI for ICMED quality management system certification and ICMED Plus product certification to AHPI for enabling 1 Step Beyond Endorsement and shall provide all technical support to AHPI in managing and promoting the Scheme(s).

“This MoU will give a big push to manufacturing and innovation in Indian medical device industry while promoting Indian healthcare sector as a whole. This initiative will also help reduce country’s huge import dependency in medical device sector while encouraging exports,” said Mr Rajiv Nath, Forum Co-ordinator of AIMED.

Dr. Girdhar Gyani, Director General, AHPI added that member hospitals are committed in providing cost effective quality health care to the community and strongly feel the need for access to indigenous high quality dependable products especially considering the need to be competitive in healthcare delivery more so in context of recently launched Ayushman Bharat project. We need sooner than later our own products and certification schemes, which can be progressively brought at par with the global benchmarks.”

Under the joint mechanism, both associations will soon roll out activities to achieve the objectives of this MoU.

Read Next

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya
News
June 5, 2026

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya

Union Health Minister J P Nadda on Thursday declared that the Central Government remains firmly committed to strengthening healthcare infrastructure across the Northeast and ensuring that advanced medical services reach people living in remote and underserved areas of the region. Nadda made these remarks while inaugurating ARHI Hospital in Meghalaya’s Ri-Bhoi district- a new super-specialty […]
Article by: IMT News Desk
Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today
News
June 5, 2026

Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today

Mumbai-based Hexagon Nutrition Ltd has mobilised Rs 41.66 crore from anchor investors ahead of its initial public offering (IPO), which opened for public subscription on June 5 and will remain open until June 9, 2026. According to a circular uploaded on BSE’s website, the company allotted a total of 92.57 lakh equity shares to anchor […]
Article by: IMT News Desk
Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval
News
June 5, 2026

Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval

Otsuka Pharmaceutical has reported that its approved kidney disease drug Voyxact (sibeprenlimab) preserved kidney function over 12 months in a late-stage clinical study, marking a significant milestone in the treatment of immunoglobulin A nephropathy (IgAN), a serious autoimmune condition that progressively damages the kidneys. In the Phase 3 VISIONARY trial involving 320 participants, patients who […]
Article by: IMT News Desk
Akums Receives European CEP Approval for Cefpodoxime Proxetil
News
June 4, 2026

Akums Receives European CEP Approval for Cefpodoxime Proxetil

Akums Drugs & Pharmaceuticals Ltd. has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its active pharmaceutical ingredient (API), Cefpodoxime Proxetil. The CEP certification confirms that Akums’ manufacturing process and quality standards for Cefpodoxime Proxetil comply with the requirements of the European Pharmacopoeia. The […]
Article by: IMT News Desk